SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
16 references·0 citing·34 second hop
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene? (2020)Strategic Patenting by Pharmaceutical Com…Strategic Accumulation of Patents in the Pharmaceutical Industry and Patent Thickets in Complex Technologies – Two Different Concepts Sharing Similar Features (2017)Strategic Accumulation of Pat…The High Cost of Prescription Drugs in the United States (2016)The High Cost of Prescription…Competition Law (2015)Competition LawPolymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents (2012)Polymorphs and Prodrugs and S…Pharmaceutical Research and Development: What Do We Get for All that Money? (2012)Pharmaceutical Research and D…Diagnosing the decline in pharmaceutical R&D efficiency (2012)Diagnosing the decline in pha…When Do Generics Challenge Drug Patents? (2011)When Do Generics Challenge Dr…The productivity crisis in pharmaceutical R&D (2011)The productivity crisis in ph…Intellectual Property and Competition Law: New Frontiers (2011)Intellectual Property and Com…IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law (2010)IP and Antitrust: An Analysis…Article 82 EC as Remedy to Patent System Imperfections: Fighting Fire with Fire? (2009)Article 82 EC as Remedy to Pa…The Interface Between Intellectual Property Rights and Competition Policy (2007)The Interface Between Intelle…A New Trade Framework for Global Healthcare R&D (2004)A New Trade Framework for Glo…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Capitalism, Socialism and Democracy (1997)Capitalism, Socialism and Dem…The Patent Controversy in the Nineteenth Century (1950)The Patent Controversy in the…Patents and Innovation: An Empirical Study (1986)Appropriating the Returns from Industrial Research and Development (1987)Determinants of Market Exclusivity for Prescription Drugs in the United States (2017)Patents, trade and medicines: past, present and future (2019)What is the impact of intellectual property rules on access to medicines? A systematic review (2022)Rise and fall of modern medicine (1999)Can the pharmaceutical industry reduce attrition rates? (2004)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Are Ideas Getting Harder to Find? (2020)Generating Theory by Abduction (2021)Lessons from 60 years of pharmaceutical innovation (2009)Market spiral pricing of cancer drugs (2013)Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? (2014)R&D Costs of New Medicines: A Landscape Analysis (2021)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Changing R&D models in research-based pharmaceutical companies (2016)A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions (2021)How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment (2021)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Patent Hold‐Up and Antitrust: How A Well‐Intentioned Rule Could Retard Innovation (2012)Strategic Management of Intellectual Property: An Integrated Approach (2013)Ten Things to do About Patent Holdup of Standards (and One Not To) (2016)Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights (2004)The public domain: enclosing the commons of the mind (2009)Recent Research on the Economics of Patents (2012)Clinical development success rates for investigational drugs (2014)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Dynamic capabilities and strategic management (1997)The Promise of Entrepreneurship as a Field of Research (2000)The Google search case in Europe: tying and the single monopoly profit theorem in two-sided markets (2018)
this work references cited by second hop

References

  • 1997Capitalism, Socialism and Democracy15,265 cited
  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2012Diagnosing the decline in pharmaceutical R&D efficiency1,978 cited
  • 2011The productivity crisis in pharmaceutical R&D918 cited
  • 2016The High Cost of Prescription Drugs in the United States591 cited
  • 1950The Patent Controversy in the Nineteenth Century585 cited
  • 2012Pharmaceutical Research and Development: What Do We Get for All that Money?256 cited
  • 2012Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents170 cited
  • 2010IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law130 cited
  • 2015Competition Law125 cited
  • 2004A New Trade Framework for Global Healthcare R&D109 cited
  • 2011When Do Generics Challenge Drug Patents?100 cited
  • 2009Article 82 EC as Remedy to Patent System Imperfections: Fighting Fire with Fire?39 cited
  • 2007The Interface Between Intellectual Property Rights and Competition Policy32 cited
  • 2017Strategic Accumulation of Patents in the Pharmaceutical Industry and Patent Thickets in Complex Technologies – Two Different Concepts Sharing Similar Features

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

21 cited
  • 2011Intellectual Property and Competition Law: New Frontiers15 cited
  • Cited by

    No citing works inside the corpus for this window.